Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Matrix-tuned hyaluronic nanofibrils promoting regenerative ocular surfacing with minimal scarring.

Biofabrication·2026
Same author

Efficacy and Safety of Pelubiprofen for Primary Dysmenorrhea: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover Trial.

Journal of clinical medicine·2026
Same author

Time-point-based analysis of gold nanoparticles in MCF-7 cells following ultrasound irradiation: quantitative and label-free intracellular characterization.

Nanoscale advances·2026
Same author

Anisotropic gold nanochains with dual-ligand interfaces for theranostic immune activation.

RSC advances·2026
Same author

An Update on Fertility Preservation From the Asian Society for Fertility Preservation.

The journal of obstetrics and gynaecology research·2026
Same author

Translational roadmap of BBB-targeted nanoparticle strategies for neuroregenerative therapy in neurodegenerative diseases.

Biomaterials science·2026

Related Experiment Video

Updated: Jun 17, 2025

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

7.8K

Injectable Biomimetic Hydrogel Constructs for Cell-Based Menopausal Hormone Therapy with Reduced Breast Cancer

Chungmo Yang1,2, Heeseon Yang1,3, Hyerim Kim2

  • 1Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea.

Biomaterials Research
|August 13, 2024
PubMed
Summary
This summary is machine-generated.

Cell-based hormone replacement therapy (HRT) using injectable ovarian cell-laden hydrogel beads offers a safer alternative to traditional HRT. This novel approach alleviates menopausal symptoms and may reduce breast cancer risk compared to pharmaceutical HRT.

More Related Videos

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K
Hyaluronic-Acid Based Hydrogels for 3-Dimensional Culture of Patient-Derived Glioblastoma Cells
08:35

Hyaluronic-Acid Based Hydrogels for 3-Dimensional Culture of Patient-Derived Glioblastoma Cells

Published on: August 24, 2018

13.0K

Related Experiment Videos

Last Updated: Jun 17, 2025

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

7.8K
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

12.2K
Hyaluronic-Acid Based Hydrogels for 3-Dimensional Culture of Patient-Derived Glioblastoma Cells
08:35

Hyaluronic-Acid Based Hydrogels for 3-Dimensional Culture of Patient-Derived Glioblastoma Cells

Published on: August 24, 2018

13.0K

Area of Science:

  • Reproductive Biology
  • Biomaterials Science
  • Endocrinology

Background:

  • Pharmaceutical hormone replacement therapy (HRT) is widely used but carries safety concerns.
  • Cell-based HRT using engineered constructs offers a potential alternative with fewer side effects.

Purpose of the Study:

  • To develop and evaluate micro-sized ovarian cell-laden hydrogel beads (GTBs) as an injectable, cell-based HRT.
  • To assess the efficacy and safety of GTB-based HRT in a menopausal rat model.

Main Methods:

  • Constructed granulosa/theca cell-laden microbeads (GTBs) to mimic ovarian crosstalk.
  • Assessed GTB ovarian hormone production in vitro for 90 days.
  • Administered GTBs to a menopausal rat model to evaluate therapeutic effects.

Main Results:

  • GTB-injected rats restored endocrine function, showing endometrial regeneration and some regular estrous cycles.
  • GTB treatment alleviated menopausal symptoms like weight gain and osteoporosis.
  • GTB-treated rats showed reduced mammary gland hyperplasia and a potentially lower breast cancer risk compared to pharmaceutical HRT.

Conclusions:

  • Injectable GTB-based HRT is a viable cell-based alternative for menopausal symptom management.
  • This approach demonstrates potential for improved safety, particularly regarding breast cancer risk, compared to conventional HRT.